Immunomic Therapeutics adds Dr. Antonio Chiocca to scientific advisory board

Neurosurgeon Antonio Chiocca, MD, PhD, was recently appointed to the scientific advisory board of Immunomic Therapeutics.

Advertisement

Four things to know:

1. Dr. Chiocca has almost 25 years of experience in neuro-oncology and neurosurgery.

2. He is the Harvey W. Cushing professor of neurosurgery at Harvard Medical School in Boston as well as neurosurgeon-in-chief and chairman of the department of neurosurgery at Brigham and Women’s Hospital, also in Boston.

3. Dr. Chiocca specializes in engineering biologic agents into selective anticancer agents, with a focus on brain tumors.

4. His work was featured in the Journal of Neurosurgery, Molecular Therapy as well as Neuro-oncology, and he served as president of the Society for Neuro-Oncology from 2015 to 2017.

More articles on devices:
‘A dream come true’: Dr. Jorge Chahla strives for success at Rush
New York hospital invests $2M in imaging system for spine, brain — 4 things to know
What Stryker’s spine division stands to gain from 5 acquisitions 

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.